Cardiology, Pain Management

This company is a specialty biopharmaceutical company that develops drugs specifically for the acute-care hospital setting. The company has developed an intravenous calcium channel (bioactive proteins that regulate blood pressure) blocker medication indicated for short term treatment of hypertension during hospitalization. The company has also developed an injectable morphine analgesic that utilizes the company’s proprietary extended-release liposome delivery system, and is indicated for pain management after major surgery. Additionally, the company has produced a bio-adherent oral gel indicated for the management of pain after oral surgery.  



Click here for more information

The comments are closed.